HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hongli Li Selected Research

IMC-EB10

2/2005Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice.
8/2004Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hongli Li Research Topics

Disease

51Neoplasms (Cancer)
06/2022 - 06/2002
21Neoplasm Metastasis (Metastasis)
01/2022 - 06/2002
15Breast Neoplasms (Breast Cancer)
12/2021 - 01/2011
10Inflammation (Inflammations)
01/2022 - 06/2010
10Stomach Neoplasms (Stomach Cancer)
01/2021 - 03/2014
9Hypoxia (Hypoxemia)
01/2022 - 05/2015
9Glioma (Gliomas)
11/2021 - 02/2013
7Heart Failure
01/2022 - 12/2015
7Carcinogenesis
11/2021 - 05/2006
6Lung Neoplasms (Lung Cancer)
06/2022 - 06/2010
6Hodgkin Disease (Hodgkin's Disease)
10/2020 - 10/2016
6Prostatic Neoplasms (Prostate Cancer)
02/2018 - 01/2010
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 08/2014
5Atherosclerosis
07/2021 - 01/2007
5Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2015
4Lymphoma (Lymphomas)
07/2022 - 07/2015
4Adenocarcinoma of Lung
01/2022 - 10/2018
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2020
4Pancreatitis
12/2019 - 01/2017
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 08/2004
4Atrial Fibrillation
10/2017 - 02/2009
3Body Weight (Weight, Body)
01/2022 - 11/2019
3Type 2 Diabetes Mellitus (MODY)
12/2021 - 03/2018
3Pneumonia (Pneumonitis)
08/2021 - 06/2010
3COVID-19
08/2021 - 09/2020
3Stroke (Strokes)
07/2021 - 06/2018
3Cardiovascular Diseases (Cardiovascular Disease)
05/2021 - 01/2019
3Lymphatic Metastasis
01/2021 - 10/2018
3Fibrosis (Cirrhosis)
01/2021 - 11/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 07/2009
3Myocardial Infarction
01/2020 - 01/2018
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2019 - 01/2016
3Esophageal Squamous Cell Carcinoma
05/2019 - 04/2016
3Hemolysis
01/2019 - 09/2015
3Ischemia
06/2018 - 05/2015
3Circulating Neoplastic Cells
02/2018 - 04/2015
3Leukemia
10/2016 - 08/2004
2Carcinoma (Carcinomatosis)
06/2022 - 03/2020
2Neuroinflammatory Diseases
01/2022 - 01/2020
2AIDS-Related Complex (ARC)
11/2021 - 01/2021
2Peripheral Nervous System Diseases (PNS Diseases)
11/2021 - 03/2019
2Critical Illness (Critically Ill)
08/2021 - 01/2021
2Thrombosis (Thrombus)
08/2021 - 04/2020
2Pulmonary Hypertension
08/2021 - 04/2020
2Dysarthria (Spastic Dysarthria)
07/2021 - 06/2018
2Rupture
07/2021 - 11/2016
2Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2020
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021 - 01/2014
2Colitis
11/2020 - 01/2018
2Obesity
10/2020 - 11/2019
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2019 - 01/2019
2Epilepsy (Aura)
11/2019 - 07/2012
2Edema (Dropsy)
04/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
04/2021 - 03/2005
21MicroRNAs (MicroRNA)IBA
01/2022 - 03/2014
11Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2013
10Biological ProductsIBA
01/2022 - 01/2007
7Messenger RNA (mRNA)IBA
03/2019 - 07/2009
6EnzymesIBA
01/2021 - 08/2004
6Matrix Metalloproteinases (MMPs)IBA
01/2016 - 07/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 06/2002
5Circular RNAIBA
01/2022 - 01/2019
5ImmunosorbentsIBA
01/2021 - 08/2004
5Pharmaceutical PreparationsIBA
01/2021 - 02/2016
5CytokinesIBA
01/2019 - 06/2010
4Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2016
4Long Noncoding RNAIBA
01/2021 - 10/2018
4Small Interfering RNA (siRNA)IBA
11/2020 - 11/2013
4CalciumIBA
11/2019 - 01/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 01/2011
33' Untranslated Regions (3' UTR)IBA
12/2021 - 01/2016
3CateninsIBA
08/2021 - 06/2017
3Caspase 3 (Caspase-3)IBA
01/2021 - 05/2015
3InflammasomesIBA
11/2020 - 01/2018
3Oxygen (Dioxygen)IBA
01/2020 - 01/2016
3ChemokinesIBA
01/2019 - 01/2015
3catalpolIBA
06/2018 - 04/2014
3Rituximab (Mabthera)FDA Link
03/2018 - 01/2018
3Vincristine (Oncovin)FDA LinkGeneric
01/2018 - 01/2016
3LigandsIBA
01/2017 - 12/2013
3AntibodiesIBA
08/2014 - 09/2004
2LipidsIBA
04/2022 - 01/2020
2urotensin IIIBA
10/2021 - 01/2021
2TroponinIBA
08/2021 - 01/2021
2MyoglobinIBA
08/2021 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 01/2016
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 01/2021
23,4-dihydroxyphenyllactic acidIBA
11/2020 - 01/2018
2Tumor Biomarkers (Tumor Markers)IBA
05/2020 - 05/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2005
2CeruletideIBA
12/2019 - 01/2018
2Histones (Histone)IBA
12/2019 - 08/2010
2PectinsIBA
11/2019 - 01/2019
2AntigensIBA
05/2019 - 05/2015

Therapy/Procedure

24Therapeutics
07/2022 - 01/2010
9Drug Therapy (Chemotherapy)
06/2022 - 03/2014
3Qigong (Qi Gong)
07/2021 - 06/2018
2Radiotherapy
10/2020 - 01/2016
2Injections
04/2020 - 02/2005
2Aftercare (After-Treatment)
10/2019 - 01/2018